← Back to screener

BioAge Labs, Inc. BIOA

Rank #2037 · Nasdaq · $0.3B market cap
Audited by KPMG LLP, no going-concern flag in the latest filing.
Score
35.7
P/E
-3.7
P/B
-1.50
ROE
41.0%
Op. Margin
–%
Debt Ratio
-20%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -3.7x, P/B -1.50x. Ranks in the top 97% of the universe.

Profitability ★★★★☆
Excellent

ROE 41.0%. Ranks in the top 10% of the universe.

Safety ★★★★★
Excellent

Debt ratio -20%. Ranks in the top 7% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2024–$-0.0B$-0.1B$-0.1B–-59
2025$0.0B$-0.1B$-0.1B$-0.2B–-20

← See the full screener